Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
-
SciScore for 10.1101/2020.10.27.357350: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Multiple sequence alignment for the above eight sequences was carried out using the MAFFT program with the L-INS-i method50 and visualized using Jalview51 (Fig. MAFFTsuggested: (MAFFT, RRID:SCR_011811)The PCA was performed using the scikit-learn package. scikit-learnsuggested: (scikit-learn, RRID:SCR_002577)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial …
SciScore for 10.1101/2020.10.27.357350: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Multiple sequence alignment for the above eight sequences was carried out using the MAFFT program with the L-INS-i method50 and visualized using Jalview51 (Fig. MAFFTsuggested: (MAFFT, RRID:SCR_011811)The PCA was performed using the scikit-learn package. scikit-learnsuggested: (scikit-learn, RRID:SCR_002577)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-